Prevalence and trends of cigarette smoking among adults with HIV infection compared with the general population in Korea
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES This study compared the current smoking prevalence among adults with human immunodeficiency virus (HIV) infection to that of the general Korean population and analyzed changes in smoking prevalence and cessation rates from 2009 to 2020. METHODS The study included a total of 10,980 adults with HIV infection who underwent a health screening examination (National Health Insurance Service-National Health Information Database; NHIS-NHID), 1,230 individuals with HIV infection who participated in the Korea HIV/AIDS Cohort (KoCosHIV), and 76,783 participants from the Korea National Health and Nutrition Examination Survey (KNHANES). We estimated the current smoking prevalence and the quit ratio, defined as the ratio of former smokers to ever-smokers. RESULTS In the NHIS-NHID and KoCosHIV studies, the prevalence of current and former smoking among adults with HIV was 44.2% (95% confidence interval [CI], 43.2 to 45.1) and 15.6% (95% CI, 14.9 to 16.3), and 47.7% (95% CI, 43.7 to 51.8) and 16.9% (95% CI, 11.8 to 22.0), respectively. In the KNHANES, these rates were 22.5% and 18.1%, respectively. The standardized prevalence ratio of current smoking among adults with HIV was 1.76 in the NHIS-NHID and 1.97 in the KoCosHIV. Furthermore, the likelihood of quitting smoking was lower among adults with HIV than in the general population (NHIS-NHID: 26.1%; 95% CI, 25.0 to 27.1; KoCosHIV: 26.2%; 95% CI, 20.2 to 32.1; KNHANES: 44.6%; 95% CI, 44.5 to 44.6). Among HIV-positive adults, there was a 1.53% decline in the current smoking rate and a 2.86% increase in the quit ratio. CONCLUSIONS Adults with HIV were more likely to smoke and less likely to quit smoking than the general adult population. Tobacco screening and cessation strategies should specifically target this population.
Abstract
OBJECTIVES This study compared the current smoking prevalence among adults with human immunodeficiency virus (HIV) infection to that of the general Korean population and analyzed changes in smoking prevalence and cessation rates from 2009 to 2020. METHODS The study included a total of 10,980 adults with HIV infection who underwent a health screening examination (National Health Insurance Service-National Health Information Database; NHIS-NHID), 1,230 individuals with HIV infection who participated in the Korea HIV/AIDS Cohort (KoCosHIV), and 76,783 participants from the Korea National Health and Nutrition Examination Survey (KNHANES). We estimated the current smoking prevalence and the quit ratio, defined as the ratio of former smokers to ever-smokers. RESULTS In the NHIS-NHID and KoCosHIV studies, the prevalence of current and former smoking among adults with HIV was 44.2% (95% confidence interval [CI], 43.2 to 45.1) and 15.6% (95% CI, 14.9 to 16.3), and 47.7% (95% CI, 43.7 to 51.8) and 16.9% (95% CI, 11.8 to 22.0), respectively. In the KNHANES, these rates were 22.5% and 18.1%, respectively. The standardized prevalence ratio of current smoking among adults with HIV was 1.76 in the NHIS-NHID and 1.97 in the KoCosHIV. Furthermore, the likelihood of quitting smoking was lower among adults with HIV than in the general population (NHIS-NHID: 26.1%; 95% CI, 25.0 to 27.1; KoCosHIV: 26.2%; 95% CI, 20.2 to 32.1; KNHANES: 44.6%; 95% CI, 44.5 to 44.6). Among HIV-positive adults, there was a 1.53% decline in the current smoking rate and a 2.86% increase in the quit ratio. CONCLUSIONS Adults with HIV were more likely to smoke and less likely to quit smoking than the general adult population. Tobacco screening and cessation strategies should specifically target this population.
참고문헌 (32)
- Dai X, "Evolution of the global smoking epidemic over the past half century : strengthening the evidence base for policy action", Tob Control, 31, pp.129~137 (2022)[DOI]
- Chang Y, "Long-term trends in smoking prevalence and its socioeconomic inequalities in Korea, 1992-2016", Int J Equity Health, 18, pp.148~ (2019)[DOI]
- Helleberg M, "Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America", AIDS, 29, pp.221~229 (2015)[DOI]
- Jones TP, "Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV : cross-sectional and longitudinal analyses", HIV Med, 23, pp.209~226 (2022)[DOI]
- Helleberg M, "Risk of cancer among HIV-infected individuals compared to the background population : impact of smoking and HIV", AIDS, 28, pp.1499~1508 (2014)[DOI]
- Mdodo R, "Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States : cross-sectional surveys", Ann Intern Med, 162, pp.335~344 (2015)[DOI]
- Frazier EL, "Trends in cigarette smoking among adults with HIV compared with the general adult population, United States-2009-2014", Prev Med, 111, pp.231~234 (2018)[DOI]
- Bien-Gund CH, "Persistent disparities in smoking rates among PLWH compared to the general population in Philadelphia, 2009-2014", AIDS Behav, 25, pp.148~153 (2021)[DOI]
- Lam JO, "Smoking and cessation treatment among persons with and without HIV in a U. S. integrated health system", Drug Alcohol Depend, 213, pp.108128~ (2020)[DOI]
- Giles ML, "Smoking and HIV : what are the risks and what harm reduction strategies do we have at our disposal?", AIDS Res Ther, 15, pp.26~ (2018)[DOI]
- Sanford BT, "Optimizing tobacco treatment delivery for people with HIV : trial protocol for a randomized controlled trial", Addict Sci Clin Pract, 17, pp.61~ (2022)[DOI]
- Foster MG, "Optimizing the implementation of tobacco treatment for people with HIV : a pilot study", Int J Environ Res Public Health, 19, pp.12896~ (2022)[DOI]
- Yoo M, "Characteristics of adolescents and young adults with HIV in the Republic of Korea from 2010 through 2015", Sci Rep, 10, pp.9384~ (2020)[DOI]
- Lee J, "Cohort profile : the National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)[DOI]
- Park B, "Mortality and causes of death among individuals diagnosed with human immunodeficiency virus in Korea, 2004-2018 : an analysis of a nationwide population-based claims database", Int J Environ Res Public Health, 19, pp.11788~ (2022)[DOI]
- Choi BY, "Korea HIV", AIDS Cohort Study : study design and baseline characteristics, 2018, pp.40, e2018023~
- Kweon S, "Data resource profile : the Korea National Health and Nutrition Examination Survey(KNHANES)", Int J Epidemiol, 43, pp.69~77 (2014)[DOI]
- Clegg LX, "Estimating average annual per cent change in trend analysis", Stat Med, 28, pp.3670~3682 (2009)[DOI]
- Helleberg M, "Mortality attributable to smoking among HIV-1-infected individuals : a nationwide, population-based cohort study", Clin Infect Dis, 56, pp.727~734 (2013)[DOI]
- De Socio GV, "Smoking habits in HIV-infected people compared with the general population in Italy : a cross-sectional study", BMC Public Health, 20, pp.734~ (2020)[DOI]
- Weinberger AH, "Sex differences in tobacco use among persons living with HIV", AIDS : a systematic review and meta-analysis, 2017, pp.74, 439~453
- Lee ES, "Awareness of Korean adults smokers about national smoking cessation program in Korea : findings from the 2016 International Tobacco Control Policy Evaluation Survey_Korea", J Korean Soc Res Nicotine Tob, 9(Suppl S1), pp.S22~S30 (2018)[DOI]
- Kim JH, "Health behaviors before and after the implementation of a health community organization : Gangwon’s Health-Plus community program", J Prev Med Public Health, 56, pp.487~494 (2023)[DOI]
- Regan S, "Determinants of smoking and quitting in HIV-infected individuals", PLoS One, 11, pp.e0153103~ (2016)[DOI]
- Ashare RL, "Differences in the rate of nicotine metabolism among smokers with and without HIV", AIDS, 33, pp.1083~1088 (2019)[DOI]
- Allenby CE, "Precision medicine for tobacco dependence : development and validation of the nicotine metabolite ratio", J Neuroimmune Pharmacol, 11, pp.471~483 (2016)[DOI]
- Schnoll RA, "Brief report : rate of nicotine metabolism and tobacco use among persons with HIV : implications for treatment and research", J Acquir Immune Defic Syndr, 80, pp.e36~e40 (2019)[DOI]
- Mauleti IY, "Factors associated with long-term retention in antiretroviral therapy among people living with HIV : evidence from a tertiary hospital in Jakarta, Indonesia", J Prev Med Public Health, 57, pp.252~259 (2024)[DOI]
- Mercié P, "Efficacy and safety of varenicline for smoking cessation in people living with HIV in France(ANRS 144 Inter-ACTIV) : a randomised controlled phase 3 clinical trial", Lancet HIV, 5, pp.e126~e135 (2018)[DOI]
- Ashare RL, "Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV", Drug Alcohol Depend, 200, pp.26~33 (2019)[DOI]
- Park MB, "Does South Korea have hidden female smokers : discrepancies in smoking rates between self-reports and urinary cotinine level", BMC Womens Health, 14, pp.156~ (2014)[DOI]
- Wacholder S, "Non-differential misclassification and bias towards the null : a clarification", Occup Environ Med, 52, pp.557~558 (1995)[DOI]